Orthopaedic Research Society (ORS) — Annual Meeting (Annual Meeting)

The Orthopaedic Research Society (ORS) Annual Meeting is a leading global scientific conference focused on musculoskeletal research and orthopaedic investigations. Based on the official ORS “Future Annual Meetings” page, the upcoming scheduled editions include:

• ORS 2027 Annual Meeting — San Francisco, California, USA
  Moscone West Convention Center — February 19 – 23, 2027
• ORS 2028 Annual Meeting — New Orleans, Louisiana, USA
  Hyatt Regency New Orleans — February 11 – 15, 2028
• ORS 2029 Annual Meeting — Portland, Oregon, USA
  Oregon Convention Center — February 2 – 6, 2029

The meeting structure also includes abstract submission windows for 2027:

• Abstract Submission: June 15 – August 31
• Late Breaking Abstract Submission: October 12 – November 9

1️⃣ Who attends (BUYERS / ATTENDEES)

ORS Annual Meeting attendance is research-driven and includes both scientific and commercial stakeholders, typically spanning early-stage investigators through senior academic leadership and industry research/go-to-market teams. For buyer targeting purposes, “buyers” are best interpreted as the decision-makers and influencers who sponsor, exhibit, support, collaborate, or purchase services that enable research translation, clinical programs, publishing, data/analytics, and orthopaedic product development.

Main attendee groups (buyer-like stakeholders)

1. Orthopaedic researchers and academic clinicians Includes professors, department chairs, research lab leaders, and clinicians presenting translational findings. They often influence partner selection and external collaboration priorities.
2. Industry research & development leaders Typical buyer-side titles include R&D directors, scientific affairs leaders, translational medicine leads, and preclinical/clinical program managers for orthopaedic products.
3. Clinical research professionals and translational teams Includes clinical operations leads, study design/biostatistics leadership, regulatory/medical affairs decision-makers, and research governance leaders.
4. Medical device and orthopaedic implant companies Buyer-like teams frequently include marketing and product commercialization leaders tied to scientific credibility, evidence generation, and registry/outcomes partnerships.
5. Biologics, regenerative medicine, and therapeutics organizations These groups attend to connect with musculoskeletal biology, tendon/ligament/cartilage science, and outcomes researchers.
6. Service and enablement vendors Research services (CROs), data/platform providers, imaging/biomechanics solution teams, and publication/support service organizations also appear in the ecosystem through sponsorships or engagement opportunities.

How we recommend we frame this event for buyer relevance: ORS is not only about “general conference attendees.” It is a concentrated environment where industry buyers need scientific adjacency: evidence, collaborators, and product validation pathways in orthopaedics and musculoskeletal science.

2️⃣ Where the show is happening + attendee geographic origin

ORS 2027 location (official): Moscone West Convention Center, San Francisco, California, USA.

Attendee geographic origin (high-level pattern): ORS Annual Meeting typically draws a strong international scientific community, but it is also deeply anchored in North American research and clinical orthopaedics networks.

Where buyers and researchers come from

• Primary base: United States (major concentration from academic medical centers and industry R&D hubs)
• Strong international participation: Europe and other regions with active orthopaedic research communities
• Cross-continental collaboration focus: buyers often attend specifically to locate research partners, evidence frameworks, and translational networks

For lead generation and buyer outreach, we usually prioritize targeting organizations with:

• US research footprints
• Orthopaedic device or musculoskeletal therapeutics programs
• Clinical research infrastructure or translational medicine units
• R&D collaborations with universities and hospitals

3️⃣ Audience reach (Local / National / Global)

Audience reach: Global scientific relevance with a strong national (US) core for ORS Annual Meeting editions in the United States.

• Local: San Francisco Bay Area / California participation is naturally elevated during ORS 2027
• National: US-based orthopaedic research institutions, industry R&D teams, and clinical research organizations participate heavily
• Global: ORS attracts international researchers and industry partners due to the discipline focus (musculoskeletal limitations, orthopaedic biology, translational research)

Practical implication for buyer fit: A buyer list collected from this event tends to skew toward evidence-oriented decision-makers and scientific affairs leaders rather than purely operational attendees.

4️⃣ Sample buyer company names (BUYERS ONLY) + Websites

Below is a buyer-focused sample list of organizations that are commonly aligned with ORS-type research ecosystems (orthopaedic devices, surgical technologies, biologics/regenerative medicine, and orthopaedic therapeutics). These are examples to support outreach planning; final prioritization should reflect the specific sponsor/exhibitor roster we can validate for the selected ORS year.

Top 5 sample companies to prioritize for initial outreach (buyer coverage mix)

• Stryker
• Medtronic
• Zimmer Biomet
• Smith+Nephew
• Arthrex

Note on validation: We recommend validating the exact sponsor/exhibitor presence for the specific ORS year before finalizing the “best buyer list,” because buyer attendance intensity varies by edition.

5️⃣ Job profiles, industries & event type

Best job profiles to target

• Director / Head of Scientific Affairs (Orthopaedics / Musculoskeletal)
• Clinical Evidence Lead / Director, Clinical Research
• Translational Medicine Lead / Translational Research Director
• Medical Affairs Director / Senior Medical Affairs Manager
• R&D Director (Orthopaedic Devices / Biomechanics)
• Preclinical Program Manager / Preclinical Research Lead
• Spine Program Manager / Spine Outcomes Lead
• Study Design & Protocol Lead (Clinical Research)
• Director, Real-World Evidence (RWE) / Outcomes Analytics
• Partnerships Manager (Academic/Industry Collaboration)
• MSL (Medical Science Liaison) — musculoskeletal indications

Industries (event-type alignment)

ORS Annual Meeting naturally attracts organizations in the orthopaedic research and translational medicine ecosystem, including:

• Medical Devices & Orthopaedic Implants
• Surgical Technology & Sports Medicine
• Biologics / Regenerative Medicine
• Pharmaceutical Therapeutics (musculoskeletal-related indications)
• CRO / Clinical Research Services
• Real-World Evidence & Outcomes Analytics
• Life Sciences Research Tools & Imaging Enablement

Event type

Primary event type: Scientific research conference / medical research congress
Secondary event type: Orthopaedics, musculoskeletal biology, translational medicine, evidence generation ecosystem

6️⃣ Estimated attendance (expected total footfall)

We can estimate attendance as a mid-to-high thousands participant conference for a specialty research meeting (research abstracts, academic participation, and industry scientific/exhibit engagement).

Working estimate: approximately 4,000–7,000 total attendees for a typical ORS Annual Meeting edition, with additional overflow from affiliated sessions and related program tracks.

Buyer density expectation: moderate to high for scientific affairs, clinical evidence, translational leadership, and R&D collaboration decision-makers—because the event is inherently research-centered rather than general-interest.

7️⃣ Key focus areas & buyer engagement

Key focus areas (what buyers care about)

1. Musculoskeletal biology and orthopaedic research Buyers look for mechanistic insights and new translational pathways.
2. Translational medicine and evidence generation Companies need credible endpoints, study design insights, and collaboration routes.
3. Clinical research and program development CROs, pharma, devices, and clinical evidence teams evaluate study feasibility and investigator networks.
4. Technology enablement (imaging, measurement, lab tools) Research measurement and imaging workflows matter in orthopaedic outcomes studies.
5. Academic-industry partnerships ORS is a natural junction for partnerships between labs, clinicians, and industry research teams.

Buyer engagement angles (how we usually position outreach)

• “Scientific adjacency” outreach: align messaging to translational orthopaedic research needs
• Evidence/outcomes messaging: map to clinical evidence, RWE, study design, endpoints
• Collaboration and partnerships: connect buyer offerings to academic research pipelines
• Program support: CRO services, lab enablement, imaging/measurement tools

8️⃣ Client-product fit note (requires your client website)

To identify the best buyers aligned with your client’s specific requirements, we need the client product / service website. Please share the client website URL, and we will map your requirements to the most relevant buyer profiles and industries for ORS Annual Meeting attendees.

Once the client website is provided, we will tailor:

• Which buyer segments (devices vs. pharma vs. CRO vs. evidence/RWE vs. imaging/tools) match best
• The job titles to target for highest relevance
• The priority ordering of target accounts
• Suggested geographic emphasis (US-based vs. international research hubs)

Quick alignment examples (so we can prepare immediately):

• If your client sells orthopaedic research tools, imaging, biomechanics measurement, or lab instrumentation, we will prioritize life science and imaging enablement buyers.
• If your client sells CRO/clinical trial services, we will prioritize clinical operations and program delivery leadership.
• If your client sells evidence generation, outcomes analytics, registry or RWE platforms, we will prioritize evidence leaders and outcomes analytics teams.
• If your client sells orthopaedic devices or surgical technology, we will prioritize scientific affairs, clinical evidence, and R&D leadership.

9️⃣ Suggested industry targeting (using the provided Apollo-style industry list)

For ORS Annual Meeting, we recommend targeting industries from your provided list that best match orthopaedic research, clinical evidence, training/education adjacency, and life-science enablement. Because ORS is a specialty medical research environment, we typically focus on:

Primary recommended industries (from your list)

• Health, Wellness & Fitness
• Hospital & Health Care
• Medical Devices
• Pharmaceuticals
• Biotechnology
• Research
• Information Technology & Services (when evidence/RWE/data platforms are involved)
• Market Research (when outcomes analytics, research insights, or evidence intelligence are involved)
• Professional Training & Coaching (only if your client provides scientific education, training programs, or continuing education)

Secondary recommended industries (conditional)

• Outsourcing/Offshoring (if clinical research support is delivered via global operations)
• Insurance (rare, but relevant if evidence generation supports payer/coverage studies)
• Computer Software (only if your client platform is software-first for trials, evidence, or research workflows)
• Events Services (if your client provides event/support services specifically tied to medical conferences)

Additional notes for research & execution planning

• Selected edition focus: ORS 2027 is scheduled in San Francisco at Moscone West Convention Center from February 19–23, 2027.
• Operational timing: abstract submission windows for 2027 run June 15–August 31 and late-breaking October 12–November 9; those timelines can influence sponsor activations and engagement.
• Buyer messaging approach: position outreach around research translation, evidence generation, and clinical program enablement—those are the most “decision-making aligned” themes for ORS-type audiences.

Next step we recommend

Please share your client website so we can produce a client-specific best buyer list (companies + best titles) tailored to ORS Annual Meeting, with priority sequencing based on your exact offering and ICP.